News

Rival Group Welcomes John Cassaday to Its Board for Growth

Rival Group Welcomes John Cassaday to Its Board for Growth

Rival Group Welcomes John M. Cassaday to Its Board of Directors

Veteran media and corporate governance leader brings vast board experience to Rival Group, enhancing its rapid expansion.

Rival Group, North America's pioneering integrated market research enterprise, is thrilled to announce that John M. Cassaday has joined its Board of Directors. Cassaday is widely recognized in Canada for his notable contributions to corporate governance, executive leadership, and organizational growth. As Rival Group's parent company, this addition comes at a strategic time as they aim to bolster their presence in the U.S. market.

John Cassaday's Distinctive Career

Cassaday's impressive legacy includes serving as the Founding President and CEO of Corus Entertainment Inc. He played a crucial role in navigating the company through over 15 years of growth, cementing its status as a leader in radio, television, and global animation through its subsidiary, Nelvana. Before his tenure at Corus, Cassaday held significant executive roles at both CTV Television Network and Campbell Soup Company in Canada and the U.K.

Reflecting on his new position, Cassaday expressed enthusiasm, stating, "Rival Group is one of the few organizations building for the future of market research. By leveraging proprietary technology and in-depth research expertise, combined with an innovative AI strategy, the Rival Group is poised for swift growth in the U.S."

Leadership and Governance Experience

Cassaday boasts an extensive governance track record across major companies in North America. Currently, he serves as Chair of Janus Henderson Group plc and has previously held the position of Chair at Manulife Financial, known to some as John Hancock Insurance Company. His extensive board experience also includes leadership roles at Sysco Corporation, Irving Oil, and Spin Master, where he gained a reputable standing for his roles as Lead Director and Chair in vital audit and compensation committees.

Enhancing Strategic Guidance

Angus Reid, Board Chair of Rival Group, praised Cassaday's appointment, stating, "John's record in board governance and expertise in the U.S. market are invaluable as we navigate our growth journey. His insight will help us truly understand the complexities we face at this stage. His leadership reinforces our commitment to responsible business scaling while ensuring we have the strategic flexibility that's vital for our evolution."

Contributions Beyond Business

Beyond his corporate roles, Cassaday has significantly impacted Canada's academic and cultural sectors. He is Co-Chair of the University of Toronto's Defy Gravity Capital Campaign and is a member of the Board of Governors at the Stratford Shakespearean Festival of Canada. His past leadership includes chairing the advisory board at St. Michael's Hospital and the Dean's Advisory Board at the Rotman School of Management.

Cassaday's accomplishments have not gone unnoticed; he is a proud Member of the Order of Canada and has received numerous accolades, including the Queen's Diamond Jubilee Medal. He is also honored in both the Marketing Hall of Legends and the Canadian Music and Broadcast Industry Hall of Fame.

The Future for Rival Group

With Cassaday's expertise on board, Rival Group aims to advance its long-term growth strategy and strengthen its governance structure. The company is set on a path to reinforce its position as a leader within the North American insights landscape. Operating from its headquarters in Vancouver, Canada, Rival Group is one of the largest independent research firms in the region. By uniquely melding proprietary research technology with certified panels and expert consultancy, Rival Group efficiently delivers actionable insights to over 500 clients spanning various industries, including technology, finance, consumer goods, media, health, and public affairs.

This strategic advance is further marked by the recognition earned by Rival Group's subsidiaries, including Rival Technologies and Reach3 Insights, which have consistently ranked among the most innovative suppliers in the industry. Together, they signify Rival Group's commitment to redefining how organizations connect with people and gather insights.

Frequently Asked Questions

Who is John M. Cassaday?

John M. Cassaday is a renowned business leader from Canada with extensive experience in corporate governance and executive leadership.

What is Rival Group?

Rival Group is North America's largest independent research organization, specializing in market insights and consultancy.

What positions has Cassaday held before joining Rival Group?

Cassaday served as CEO of Corus Entertainment and held senior roles at CTV and Campbell Soup Company.

How will Cassaday's appointment benefit Rival Group?

His governance experience and market knowledge are expected to enhance Rival Group's strategic growth and scalability.

What accolades has Cassaday received for his service?

Cassaday has been designated a Member of the Order of Canada and has received various industry honors, including the Queen's Diamond Jubilee Medal.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 105

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 75

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 210

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Csquare Investors Face Tough Questions Amid Probe

Updated Category News Views 72

Csquare's Shaky Claims and Market Consequences When a company flashes big numbers like $356 million to showcase its financial health, it sure gets the ticker NYSE:CSQR buzzing. But here's the rub—over half of that is locked up tighter than a drum, off-limits for general use. You gotta appreciate the irony, right? Someone's turned up a rock and there it is, a mess of...

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 115

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 105

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 72

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Wynn Resorts Shares Insights on Fourth Quarter Financials

Updated Category News Views 148

Wynn Resorts Financial Results Announcement Wynn Resorts, Limited (NASDAQ: WYNN) has announced the upcoming financial results for the fourth quarter. Investors and stakeholders eagerly await this significant event, typically seen as a marker of the company’s performance over the holiday season and other vital periods. Date and Time of the Earnings Release The earnings...

Continue Reading
Understanding the Trust Crisis Plaguing AI Projects Today

Updated Category News Views 186

Trust Issues in AI: An Unveiling Survey In an era where artificial intelligence continues to transform industries, a recent survey sheds light on a pressing issue: trust in the content produced by AI. Conducted in early 2025, this survey dives into the concerns of various executives and knowledge managers, painting a vivid picture of the challenges that lie ahead for AI...

Continue Reading
NXP Semiconductors Declares Upcoming Dividend Payments

Updated Category News Views 125

NXP Semiconductors Declares Upcoming Dividend Payments NXP Semiconductors N.V. has recently taken a significant step in its capital return program by announcing an interim dividend. This decision reflects the company's robust capital structure and the board's unwavering confidence in its long-term growth potential. Details of the Interim Dividend Announcement The board...

Continue Reading
Empowering Patients: Shaping the Future of Rare Disease Treatment

Updated Category News Views 89

Empowering Patients in Rare Disease Drug Development This insightful webinar illuminates the pivotal role of patient-led organizations in the scientific and regulatory processes driving the development of therapies for ultra-rare diseases. By sharing their experiences and initiatives, speakers will provide a real-world context on how patient involvement has been...

Continue Reading
Upcoming Conference Call: Data Storage Corporation Insights

Updated Category News Views 96

Data Storage Corporation to Host Business Update Conference Call Data Storage Corporation (Nasdaq: DTST), a leading provider of innovative solutions, has scheduled an important conference call to discuss its progress and financial outcomes for the second quarter of the fiscal year 2025. This call is set for 11:00 a.m. Eastern Time on Thursday, August 14, 2025, marking a...

Continue Reading